Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: codeine / doxycycline attending: chief complaint: shoulder pain major surgical or invasive procedure: - coronary artery bypass graft x 5, with left internal mammary artery to left anterior descending coronary artery, reversed single saphenous vein graft from the aorta to the posterior descending coronary artery, reversed single saphenous vein graft from the aorta to the first obtuse marginal coronary artery, reversed single saphenous vein graft from the aorta to the ramus coronary artery, as well as reversed single saphenous vein graft from the aorta to the first diagonal coronary artery. history of present illness: this is a 70-year-old gentleman who recently developed some shoulder pain which correlated with exercise. he underwent a stress test which was positive and this obviously led to a catheterization. the catheterization revealed 3-vessel disease. based on his findings and his medical history of diabetes and hypertension as well as hypercholesterolemia, it was recommended he undergo coronary artery bypass graft. the patient understood the risks and benefits of the procedure, including, but not limited to bleeding, infection, myocardial infarction, stroke, death, renal and pulmonary insufficiency, as well as the possibility of a blood transfusion and future revascularization procedures, and the patient then agreed to proceed. past medical history: diabetes, diet controlled dyslipidemia hypertension social history: social history is significant for the absence of current tobacco use, quit 30yrs ago. there is no history of alcohol abuse; he drinks glasses of wine nightly. retired from medical/military electronics family history: he has several siblings with cad. he had a brother who underwent cabg at 59 and died one year later. he has one other brother and two sisters with cad. there is no family history of premature coronary artery disease or sudden death. physical exam: vs: t 98.4, bp 124/80, hr 80, rr 20, o2 sat 98% ra gen: wdwn middle aged male in nad. oriented x3. mood, affect appropriate. heent: ncat. sclera anicteric. conjunctiva were pink, no pallor or cyanosis of the oral mucosa. no xanthalesma. neck: supple with jvp of 6cm; no carotid bruits cv: pmi located in 5th intercostal space, midclavicular line. rr, normal s1, s2. no m/r/g. no thrills, lifts. no s3 or s4. chest: no chest wall deformities, scoliosis or kyphosis. resp were unlabored, no accessory muscle use. ctab, no crackles, wheezes or rhonchi. abd: soft, ntnd. no hsm or tenderness. abd aorta not enlarged by palpation. no abdominial bruits. ext: no c/c/e. no femoral bruits. skin: no stasis dermatitis, ulcers, scars, or xanthomas. . pulses: right: carotid 2+ femoral 2+ popliteal did not check dp 2+ pt 2+ left: carotid 2+ femoral 2+ popliteal did not check dp 2+ pt 2+ pertinent results: echo prebypass no atrial septal defect is seen by 2d or color doppler. the left ventricular cavity size is normal. overall left ventricular systolic function is normal (lvef>55%). right ventricular chamber size and free wall motion are normal. the descending thoracic aorta is mildly dilated. the aortic valve leaflets (3) are mildly thickened. no aortic regurgitation is seen. the mitral valve leaflets are mildly thickened. an eccentric, posteriorly directed jet of mild (1+) mitral regurgitation is seen. postbypass biventricular systolic function is preserved. the study is otherwise unchanged from prebypass. cxr the patient is after median sternotomy and cabg. there is no change in the left retrocardiac opacity most likely consistent with atelectasis. small amount of pleural effusion cannot be excluded but appears grossly unchanged compared to the prior study. there is improvement in the aeration of the right lower lung with a right small pleural effusion being unchanged. there is no evidence of failure. there is no evidence of pneumothorax. 07:05am blood wbc-8.5 rbc-3.51* hgb-10.1* hct-31.0* mcv-88 mch-28.8 mchc-32.7 rdw-15.5 plt ct-313 07:05am blood pt-19.1* inr(pt)-1.8* 07:15am blood glucose-99 urean-13 creat-0.7 na-140 k-4.0 cl-106 hco3-23 angap-15 09:09pm urine color-yellow appear-clear sp -1.013 urine blood-neg nitrite-neg protein-neg glucose-neg ketone-neg bilirub-neg urobiln-neg ph-8.0 leuks-neg brief hospital course: mr. was admitted to the on for surgical management of his coronary artery disease. he was taken directly to the operating room where he underwent coronary artery bypass grafting to five vessels. postoperatively he was taken to the cardiac surgical intensive care unit for monitoring. within 24 hours, he had awoke neurologically intact and was extubated. beta blockade, aspirin and a statin were resumed. he was then transferred to the step down unit for further recovery. he was gently diuresed towards his preoperative weight. the physical therapy service was consulted for assistance with his postoperative strength and mobility. pt did go into afib he was given amio he did convert to nsr. he is on coumadin 3 mg . his inr on dc is 1.8. as per dr . pt will follow his inr with dr . vna is set up to have inr drawn at home. they will fax the inr to dr office. if vna cannot get inr drawn. pt was given a prescription to go to the lab and have his inr drawn. the lab will fax the results to dr office. dr and the patient know that this has not been set - up. i will email dr . with the patients information. i will also attempt to page her. inr is 1.8. coumadin 3 mg is given q night. i have talled extensively with the patien. he agrees to the aforementioned format. medications on admission: hctz 25mg qd lisinopril 5mg qd aspirin 325mg qd lipitor 40mg qd toprol xl 50mg qd discharge medications: 1. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). disp:*60 capsule(s)* refills:*0* 2. ferrous sulfate 325 mg (65 mg iron) tablet sig: one (1) tablet po daily (daily) for 1 months. disp:*30 tablet(s)* refills:*0* 3. ascorbic acid 500 mg tablet sig: one (1) tablet po bid (2 times a day) for 1 months. disp:*60 tablet(s)* refills:*0* 4. hydromorphone 2 mg tablet sig: one (1) tablet po q3h (every 3 hours) as needed for pain. disp:*40 tablet(s)* refills:*0* 5. ranitidine hcl 150 mg tablet sig: one (1) tablet po once a day for 1 months. disp:*30 tablet(s)* refills:*0* 6. aspirin 81 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po daily (daily). disp:*30 tablet, delayed release (e.c.)(s)* refills:*0* 7. atorvastatin 40 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*0* 8. amiodarone 200 mg tablet sig: two (2) tablet po bid (2 times a day): please take 400mg twice a day, on decrease to 400 mg daily, then decrease to 200mg and follow up with dr . disp:*80 tablet(s)* refills:*0* 9. furosemide 20 mg tablet sig: one (1) tablet po bid (2 times a day) for 4 days. disp:*8 tablet(s)* refills:*0* 10. cephalexin 500 mg capsule sig: one (1) capsule po q6h (every 6 hours) for 10 days. disp:*40 capsule(s)* refills:*0* 11. potassium chloride 20 meq packet sig: one (1) packet po q12h (every 12 hours) for 5 days. disp:*10 packet(s)* refills:*0* 12. coumadin 3 mg tablet sig: one (1) tablet po once a day: inr goal is . disp:*30 tablet(s)* refills:*2* 13. outpatient lab work dr fax: ( inr draw fax the reslts to dr off / first draw then then per pcp 14. metoprolol tartrate 25 mg tablet sig: three (3) tablet po tid (3 times a day). disp:*270 tablet(s)* refills:*3* discharge disposition: home with service facility: homecare discharge diagnosis: cad s/p cabgx5 htn hyperlipidemia diet controlled diabetes afib discharge condition: good discharge instructions: 1) monitor wounds for signs of infection. these include redness, drainage or increased pain. in the event that you have drainage from your sternal wound, please contact the at (. 2) report any fever greater then 100.5. 3) report any weight gain of 2 pounds in 24 hours or 5 pounds in 1 week. 4) no lotions, creams or powders to incision until it has healed. you may shower and wash incision. gently pat the wound dry. please shower daily. no bathing or swimming for 1 month. use sunscreen on incision if exposed to sun. 5) no lifting greater then 10 pounds for 10 weeks. 6) no driving for 1 month. 7) call with any questions or concerns 8) pt/inr for coumadin dosing dr will follow your inr. your goal is . vna will fax the results to her office. if vna cannot draw inr you have to take the prescription to your local lab and have them draw you inr. you should do this . on dc your inr is 1.8. 1) overview of warfarin: action, daily dosing, mg strength, using pill-keeper and calendar, avoiding/management of missed doses. 2) pt/inr monitoring: given explanation of test results and goal range. stressed the importance of obtaining labwork when ordered to avoid bleeding and clotting complications. 3) medications: drug interactions reviewed, emphasizing the need to notify acms of any changes in use of prescription or otc medications (including acetaminophen) and avoidance of nsaids/asa containing drugs. specifically requested patient to notify acms of any addition of otc/herbals/supplements/prescription drugs so that potential warfarin interactions may be investigated. 4) dietary considerations: reviewed vitamin k's intraction with warfarin. stressed the importance of consistency in weekly diet, food labels for ingredients, serving sizes of vitamin k foods, avoidance of nutritional supplements and multivitamins containing vitamin k. 5) alcohol use: explained interaction with warfarin, potential increased bleeding risk associated with alcohol intake, importance of communicating changes in alcohol intake pattern with acms providers. 6) bleeding: implications reviewed including signs and symptoms of minor and major bleeding, when to call acms (mon-fri 9am-5pm) and when to call providers on call (after hour and weekends) and importance of seeking urgent care for medical emergencies. 7) safety considerations: reviewed common home safety hazards, reinforced importance of injury prevention with good lighting, nonskid rugs, and consistent seatbelt use. advised patient to carry anticoagulation id card and /or medic alert id. 8) procedures: reviewed implications related to dental, surgical, and medical procedures. emphasized the need to notify all providers of warfarin therapy and acms of upcoming procedures and any dosage recommendations made by other providers. 9) for female patients: avoiding pregnancy. reviewed potential tetrogenic effects of warfarin on the fetus. reviewed need to use effective and consistent birth control measures while taking warfarin. instructed to inform acms and pcp if planning pregnancy. also instructed patient to contact acms or pcp immediately if pregnancy occurs. followup instructions: please call to schedule appointments dr 4 weeks dr in on . call and make an appointment to have your inr followed, as discussed. this should be on . you can go to her office and have the inr checked or use the prescription that i gave you to go to an outside lab. then they will fax the results to her office. i have set up vna to draw your inr anf fax the results to her office. any three will surfice. but you must call dr to have her follow your inr. i have e-mailed her yout information. as discussed with dr we have set you up to see dr from cardiology scheduled appointments: provider: , m.d. date/time: 11:00 provider: , m.d. phone: date/time: 9:00 procedure: single internal mammary-coronary artery bypass extracorporeal circulation auxiliary to open heart surgery diagnostic ultrasound of heart (aorto)coronary bypass of four or more coronary arteries cardioplegia transfusion of packed cells diagnoses: coronary atherosclerosis of native coronary artery unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled atrial fibrillation personal history of tobacco use other and unspecified hyperlipidemia other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure family history of ischemic heart disease other vascular complications of medical care, not elsewhere classified accidents occurring in residential institution phlebitis and thrombophlebitis of upper extremities, unspecified 

Answer: The patient is high likely exposed to